Differences

This shows you the differences between two versions of the page.

--- philip_krause [2023/03/12 07:08]
liam
+++ philip_krause [2023/04/10 02:56] (current)
liam
@@ Line 13: / Line 13: @@
 Krause participated in a February 11-12, 2020 event titled "2019 novel Coronavirus Global research and innovation forum: towards a research roadmap" co-hosted by the [[World Health Organization]] [[R&D Blueprint]] and [[Global Research Collaboration for Infectious Disease Preparedness]] (GLOPID-R). He and [[Anuradha Poonepalli]] presented on the topic of "Candidate vaccines R&D".((//2019 novel Coronavirus Global research and innovation forum: towards a research roadmap AGENDA.// (2020). GLOPID-R. https://web.archive.org/web/20230208185417/https://www.glopid-r.org/wp-content/uploads/2020/02/covid-19-global-research-and-innovation-forum-2020-program.pdf))
-Krause was appointed Chair of the [[WHO R&D Blueprint COVID-19 Vaccines Working Group]] upon its creation in April 2020.((//WHO R&D Blueprint novel Coronavirus WHO Working Group - Target Product Profiles for COVID-19 Vaccines WHO reference number.// World Health Organization. Retrieved March 12, 2023, from https://web.archive.org/web/20230312032002/https://cdn.who.int/media/docs/default-source/blue-print/tors-working-group-on-target-product-profiles-covid19.pdf?sfvrsn=f209d4b4_1&download=true)) He participated in the 2nd Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions on June 10, 2021.((//2nd Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions// (p. 17). (2021). World Health Organization. https://web.archive.org/web/20230312032446/https://www.who.int/docs/default-source/coronaviruse/report-sars-global-consultation_10june2021.pdf))
+Krause was appointed Chair of the [[WHO R&D Blueprint COVID-19 Vaccines Working Group]] upon its creation in April 2020.((//WHO R&D Blueprint novel Coronavirus WHO Working Group - Target Product Profiles for COVID-19 Vaccines WHO reference number.// World Health Organization. Retrieved March 12, 2023, from https://web.archive.org/web/20230312032002/https://cdn.who.int/media/docs/default-source/blue-print/tors-working-group-on-target-product-profiles-covid19.pdf?sfvrsn=f209d4b4_1&download=true)) He participated in the [[2nd_global_consultation_on_sars-cov-2_variants_of_concern_and_their_impact_on_public_health_interventions|2nd Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions]] on June 10, 2021.((//2nd Global Consultation on SARS-CoV-2 Variants of Concern and the Impact on Public Health Interventions// (p. 17). (2021). World Health Organization. https://web.archive.org/web/20230312032446/https://www.who.int/docs/default-source/coronaviruse/report-sars-global-consultation_10june2021.pdf))
 Krause began his second term on CEPI's Scientific Advisory Committee in June 2021.((//Vaccine specialists and global health experts selected for CEPI’s Scientific Advisory Committee.// (2021, June 9). CEPI. http://archive.today/2023.02.05-121837/https://cepi.net/news_cepi/vaccine-specialists-and-global-health-experts-selected-for-cepis-scientific-advisory-committee/))